FRTCF yields 20.41% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, FRTCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FRTCF + JNJ for your $10,000?
Far East Consortium International Limited, an investment holding company, engages in the property development and investment, hotel operations and management, car park operations and facilities management, gaming and related operations, and securities and financial product investments. It develops a portfolio of residential properties; invests in retail and office buildings; and operates hotels. The company also operates third party and self-owned car parks; and owns and operates casinos and gaming facilities, as well as operated bars. In addition, it provides loan financing, sales agency, mortgage, administration and management, treasury management, vault, and hotel management and consultancy services. As of March 31, 2022, the company owned and operated 31 hotels with approximately 8,149 rooms; and managed 424 car parks with approximately 120,200 car parking bays. It has operations in Australia, New Zealand, Hong Kong, Malaysia, the Czech Republic, the People's Republic of China, Singapore, the United Kingdom, and the rest of Europe. The company was incorporated in 1990 and is based in Central, Hong Kong.
Full FRTCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.